Günay S, Parlak IS, Hezer H, Şeref Parlak E Şengül, Umut MS, Hancıoğlu Z, et al. Risk factors for the development of interstitial lung disease following severe COVID-19 pneumonia and outcomes of systemic corticosteroid therapy: 3-month follow-up: Interstitial lung disease following severe COVID-19 pneumonia. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2023 Sep. 13 [cited 2024 Jul. 27];40(3):e2023029. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/14418